Prestige Consumer Healthcare
PBH
#4019
Rank
C$3.95 B
Marketcap
C$82.27
Share price
-1.92%
Change (1 day)
-33.17%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): C$5.30

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is C$5.29. In 2024 the company made an earnings per share (EPS) of C$5.97 an increase over its 2023 EPS that were of C-$2.24.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$5.30-11.29%
2024C$5.97-367.08%
2023C-$2.24-138.33%
2022C$5.8311.7%
2021C$5.2213.6%
2020C$4.60-651.67%
2019C-$0.83-148.78%
2018C$1.71-83.29%
2017C$10.22437.23%
2016C$1.90-34.13%
2015C$2.8952.94%
2014C$1.89-8.11%
2013C$2.06
2011C$1.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.47 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
C$9.60 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.00 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.89-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.21-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
C$8.54 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
C$1.96-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.23-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
C-$41.15-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
C$1.69-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel